Exploring the Potential of Anthraquinone‐Based Hybrids for Identifying a Novel Generation of Antagonists for the Smoothened Receptor in HH‐Dependent Tumour
Chemistry – A European Journal · 2023
DOI: 10.1002/chem.202302237 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – A European Journal, 2023. Verfasst von Deborah Quaglio und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Technology of Drugs, Sapienza University of Rome, P.le Aldo Moro 5, 00185, Rome, Italy. Hauptthemen laut MEDLINE: Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Istruzione, dell'Università e della Ricerca, Associazione Italiana per la Ricerca sul Cancro, Ministero dell’Istruzione, dell’Università e della Ricerca.
Abstract (Originalsprache)
Natural products (NPs) are highly profitable pharmacological tools due to their chemical diversity and ability to modulate biological systems. Accessing new chemical entities while retaining the biological relevance of natural chemotypes is a fundamental goal in the design of novel bioactive compounds. Notably, NPs have played a crucial role in understanding Hedgehog (HH) signalling and its pharmacological modulation in anticancer therapy. However, HH antagonists developed so far have shown several limitations, thus growing interest in the design of second‐generation HH inhibitors. Through smart manipulation of the NPs core‐scaffold, unprecedented and intriguing architectures have been achieved following different design strategies. This study reports the rational design and synthesis of a first and second generation of anthraquinone‐based hybrids by combining the rhein scaffold with variously substituted piperazine nuclei that are structurally similar to the active portion of known SMO antagonists, the main transducer of the HH pathway. A thorough functional and biological investigation identified RH2_2 and RH2_6 rhein‐based hybrids as valuable candidates for HH inhibition through SMO antagonism, with the consequent suppression of HH‐dependent tumour growth. These findings also corroborated the successful application of the NPs‐based hybrid design strategy in the development of novel NP‐based SMO antagonists.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Technology of Drugs, Sapienza University of Rome, P.le Aldo Moro 5, 00185, Rome, Italy.
- Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 291, 00161, Rome, Italy.
- Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome, Viale Regina Elena 291, 00161, Rome, Italy.
- Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100, Siena, Italy.
ORCID-Profile: Francesca Ghirga
Förderung
- Ministero dell'Istruzione, dell'Università e della Ricerca
- Associazione Italiana per la Ricerca sul Cancro
- Ministero dell’Istruzione, dell’Università e della Ricerca
Zitieren
APA
Quaglio, D., Infante, P., Cammarone, S., Lamelza, L., Conenna, M., Ghirga, F., Adabbo, G., Pisano, L., Di Marcotullio, L., Botta, B., & Mori, M. (2023). Exploring the Potential of Anthraquinone‐Based Hybrids for Identifying a Novel Generation of Antagonists for the Smoothened Receptor in HH‐Dependent Tumour. Chemistry – A European Journal. https://doi.org/10.1002/chem.202302237
Vancouver
Quaglio D, Infante P, Cammarone S, Lamelza L, Conenna M, Ghirga F, et al. Exploring the Potential of Anthraquinone‐Based Hybrids for Identifying a Novel Generation of Antagonists for the Smoothened Receptor in HH‐Dependent Tumour. Chemistry – A European Journal. 2023. doi:10.1002/chem.202302237
BibTeX
@article{Quaglio2023,
author = {Quaglio, Deborah and Infante, Paola and Cammarone, Silvia and Lamelza, Lara and Conenna, Marilisa and Ghirga, Francesca and Adabbo, Gennaro and Pisano, Luca and Di Marcotullio, Lucia and Botta, Bruno and Mori, Mattia},
title = {Exploring the Potential of Anthraquinone‐Based Hybrids for Identifying a Novel Generation of Antagonists for the Smoothened Receptor in HH‐Dependent Tumour},
journal = {Chemistry – A European Journal},
year = {2023},
doi = {10.1002/chem.202302237}
}
EUVIMED